Founders Financial Securities LLC Astrazeneca PLC Transaction History
Founders Financial Securities LLC
- $1.06 Billion
- Q3 2024
A detailed history of Founders Financial Securities LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Founders Financial Securities LLC holds 13,823 shares of AZN stock, worth $876,239. This represents 0.1% of its overall portfolio holdings.
Number of Shares
13,823
Previous 12,666
9.13%
Holding current value
$876,239
Previous $987,000
9.12%
% of portfolio
0.1%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$3.99 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.66 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.36 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.33 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.22 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $196B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...